Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Adjuvant Therapy
  •  Urological Cancers
  •  Lymphoma
  •  Thoracic Oncology
  •  Hormone Therapy
  •  Bladder Cancer
  •  Radiation Therapy
  •  Surgical Oncology

Abstract

Citation: Clin Oncol. 2023;8(1):2016.DOI: 10.25107/2474-1663.2016

Rare Gastrointestinal Tumors: How Often do we Operate on Such Tumors? A Single-Center Study from a Regional Hospital

Lolis ED, Anagnou A, Vogiatzis N, Glossas Athanasoulas IN, Lianeris G and Daskalakis K

Department of General Surgery, General Hospital of Rethymno, Greece
1 Surgical Clinic, General Hospital of Chania “Saint George”, Greece
Department of General Surgery, General Hospital of Volos, Greece

*Correspondance to: Athina Anagnou 

 PDF  Full Text Research Article | Open Access

Abstract:

Background: Several types of rare tumors, benign and malignant, have infrequently been reported and dealing with them remains a challenge. Rare tumors can occur in every organ and in every age. Methods: Forty-one rare tumors of the gastrointestinal tract were identified in forty patients, operated in a secondary, regional center, over a 15-year period. According to their biological behavior they were divided into three subgroups; benign, with uncertain behavior or low malignancy and malignant. The diagnosis was set by the pathology report. Results: In most cases (61%) the tumor was the cause of surgery. Patient age ranged from 15 to 90 years old (median 61y; mean 58y), and male to female ratio was 1.22:1. Four tumors were benign (9.7%), eighteen were of uncertain behavior or low malignancy (43.9%) and nineteen were malignant (46.4%). Seventeen cases (41.4%) were located in the appendix, nine (22%) in colon, eight (19.5%) in small bowel, three in gallbladder (7.3%) and the rest occurred in stomach, omentum, Vater's ampulla and mesentery (1 case in each). Serious, life-threatening complications occurred in two patients, both with malignant tumors, but middle-aged (45 and 57 years old). Conclusion: Even non-referral centers should reveal their rare cases, so that evidence-based medicine can be achieved in every patient. In most occasions, no guidelines were available and the decision was based on surgeon's knowledge and experience. Surgeons, even in non-referral centers, must be ready to deal with every kind of neoplasm, independent of its frequency and its site.

Keywords:

Gastrointestinal tumors; Rare tumors; Gastric tumors; Small bowel tumors; Appendiceal tumors; Colorectal tumors

Cite the Article:

Lolis ED, Anagnou A, Vogiatzis N, Glossas Athanasoulas IN, Lianeris G, Daskalakis K. Rare Gastrointestinal Tumors: How Often do we Operate on Such Tumors? A Single-Center Study from a Regional Hospital. Clin Oncol. 2023;8:2016..

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Clinical Outcome for Rectal Cancer Treated with Preoperative Chemoradiotherapy (CRT) Based on the Pathological Tumor Regression Grade (TRG)
 Abstract  PDF  Full Text
Delivered Dose Verification for Lung Cancer Stereotactic Body Radiotherapy Using Cone-Beam CT
 Abstract  PDF  Full Text
View More...